CAT and metabolic dysfunction-associated steatotic liver disease: CHO‐lowering medications, including but not limited to atorvastatin, are beneficial to ameliorate NAFLD from this study as well as others’ research.[14, 15] Patients receiving statins treatment not only exhibited lower lipid and CHO levels but also showed decreased c‐CASP3 content and increased catalase levels (Figure S1J, K).